Effect of peritoneal dialysis fluid and pH on bactericidal activity of ciprofloxacin

Area of Science:

• Microbiology
• Pharmacology
• Nephrology

Background:

• Peritonitis is a serious complication in patients undergoing peritoneal dialysis.
• Antibiotic selection is crucial for treating peritonitis, but their efficacy can be influenced by the dialysis environment.
• Understanding how factors like pH and dialysis fluid affect antibiotic activity is vital for effective treatment.

Purpose of the Study:

• To evaluate the in vitro bactericidal activity of ciprofloxacin and other antibiotics against common peritonitis pathogens.
• To determine the impact of varying pH levels (5.5 and 7.4) and dialysis fluid on antibiotic efficacy.
• To compare the performance of ciprofloxacin with tobramycin, vancomycin plus rifampin, and rifampin under simulated peritoneal dialysis conditions.

Main Methods:

• In vitro assessment of bactericidal activity.
• Testing against key pathogens: Pseudomonas aeruginosa, Escherichia coli, and three strains of staphylococci.
• Evaluation across two pH conditions (5.5 and 7.4) and in dialysis fluid medium.

Main Results:

• Ciprofloxacin demonstrated consistent bactericidal activity across different pH values and in dialysis fluid.
• The efficacy of tobramycin was significantly reduced in low pH conditions.
• No significant impact of pH or medium was observed on ciprofloxacin's activity against the tested bacteria.

Conclusions:

• Ciprofloxacin is a reliable option for treating peritonitis associated with peritoneal dialysis due to its stable activity.
• The reduced efficacy of tobramycin at low pH highlights potential limitations in peritoneal dialysis fluid.
• These findings support the use of ciprofloxacin in empirical or targeted therapy for peritoneal dialysis-related peritonitis.